AlphaYouJJ
Insider buying
Jean Jacques Bienaime bought $10K of Keros Therapeutics, Inc. (KROS) stock
Jean Jacques Bienaime, Dir of Keros Therapeutics, Inc. (KROS), bought 1,000 shares of KROS stock worth $10K, per an SEC Form 4 filed Jun 17, 2026.
It was an open-market purchase.
The trade happened on Jun 15, 2026, 2 days before it was made public.
KROS has moved +14.6% since the trade date, from $10.24 to $11.73 (Sep 22, 2026 close).
- Traded
- Jun 15, 2026
- Disclosed
- Jun 17, 2026
- Filing delay
- 2 days
- Price since
- +14.6%
- Role
- Dir
- Source
- SEC Form 4
More KROS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.